Human cutaneous pigmentation a collaborative act in the skin, directed by paracrine, autocrine, and endocrine factors and the environment

From Melanocytes to Melanoma: The Progression to Malignancy

Volumn , Issue , 2006, Pages 81-100

  Abdel Malek, Zalfa A ^a   Kadekaro, Ana Luisa ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

autoimmune factors; constitutive pigmentation; endocrine factors; facultative pigmentation; Human melanocytes; paracrine factors; photoprotection

Indexed keywords

EID: 33748161411     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-994-3_5     Document Type: Chapter

References (171)

1. Pathak MA, Jimbow K, Fitzpatrick T. Photobiology of pigment cell. In: Seiji M, ed. Phenotypic Expression in Pigment Cells. University of Tokyo Press, Tokyo, Japan, 1980, pp. 655-670.
2. Fitzpatrick TB, Szabo G, Seiji M, Quevedo WC. Biology of the melanin pigmentary system. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freeberg IM, Austen KF, eds. Dermatology in General Medicine. McGraw-Hill, New York, NY, 1979, pp. 131-163.
3. Fuchs E. Epidermal differentiation: the bare essentials. J Cell Biol 1990;111:2807-2814.
4. Dillman AM. Photobiology of skin pigmentation. In: Levine N, ed. Pigmentation and Pigmentary Disorders. CRC, Boca Raton, FL, 1993, pp. 61-94.
5. Gilchrest BA, Zhai S, Eller MS, Yarosh DB, Yaar M. Treatment of human melanocytes and S91 melanoma cells with the DNA repair enzyme T4 endonuclease V enhances melanogenesis after ultraviolet irradiation. J Invest Dermatol 1993;101:666-672.
6. Kadekaro AL, Kavanagh RJ, Wakamatsu K, Ito S, Pipitone MA, Abdel-Malek ZA. Cutaneous photo-biology. The melanocyte vs. The sun: who will win the final round? Pigment Cell Res 2003;16:434-47.
7. Hunt G, Kyne S, Ito S, Wakamatsu K, Todd C, Thody AJ. Eumelanin and pheomelanin contents of human epidermis and cultured melanocytes. Pigment Cell Res 1995;8:202-208.
8. Szabo G. Racial differences in the fate of melanosomes in human epidermis. Nature 1969;222:1081.
9. Halaban R, Pomerantz SH, Marshall S, Lambert DT, Lerner AB. Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol 1983;97:480-488.
10. Abdel-Malek Z, Swope V, Collins C, Boissy R, Zhao H, Nordlund J. Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes. J Cell Sci 1993;106:1323-1331.
11. Abdel-Malek ZA, Swope VB, Nordlund JJ, Medrano EE. Proliferation and propagation of human melanocytes in vitro are affected by donor age and anatomical site. Pigment Cell Res 1994;7:116-122.
12. Iwata M, Corn T, Iwata S, Everett MA, Fuller BB. The relationship between tyrosinase activity and skin color in human foreskins. J Invest Dermatol 1990;95:9-15.
13. Halaban R, Langdon R, Birchall N, et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 1988;107:1611-1619.
14. Kock A, Schwarz T, Kirnbauer R, et al. Human keratinocytes are a source for tumor necrosis factor a: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990;172:1609-1614.
15. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 1992;267:24, 675-24, 680.
16. Chakraborty AK, Funasaka Y, Slominski A, et al. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta 1996;1313:130-138.
17. Wakamatsu K, Graham A, Cook D, Thody AJ. Characterization of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res 1997;10:288-297.
18. Abdel-Malek Z, Swope VB, Suzuki I, et al. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA 1995;92:1789-1793.
19. Pathak MA, Hori Y, Szabo G, Fitzpatrick TB. The photobiology of melanin pigmentation in human skin. In: Kawamura T, Fitzpatrick TB, Seiji M, eds. Biology of Normal and Abnormal Melanocytes. University Park Press, Baltimore, MD, 1971, pp. 149-169.
20. Kobayashi N, Nakagawa A, Muramatsu T, et al. Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J Invest Dermatol 1998;110:806-810.
21. Nordlund JJ, Abdel-Malek ZA. Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation. In: Bagnara J, ed. Advances in Pigment Cell Research Proceedings of the XIII International Pigment Cell Society. Alan R. Liss, New York, NY, 1988, pp. 219-236.
22. Gilchrest BA, Eller MS. DNA photodamage stimulates melanogenesis and other photoprotective responses. J Investig Dermatol Symp Proc 1999;4:35-40.
23. Menon IA, Persad S, Ranadive NS, Haberman HF. Photobiological effects of eumelanin and pheomelanin. In: Bagnara JT, Klaus SN, Paul E, Schartl M, eds. Biological, Molecular and Clinical Aspects of Pigmentation. University of Tokyo Press, Tokyo, Japan, 1985, pp. 77-86.
24. Bustamante J, Bredeston L, Malanga G, Mordoh J. Role of melanin as a scavenger of active oxygen species. Pigment Cell Res 1993;6:348-353.
25. Pathak MA, Fitzpatrick TB. The role of natural photoprotective agents in human skin. In: Fitzpatrick TB, Pathak MA, Haber LC, Seiji M, Kukita A, eds. Sunlight and Man. University of Tokyo Press, Tokyo, Japan, 1974, pp. 725-750.
26. Kaidbey KH, Poh Agin P, Sayre RM, Kligman AM. Photoprotection by melanin-A comparison of black and Caucasian skin. J Am Acad Dermatol 1979;1:249-260.
27. Sober AJ, Lew RA, Koh HK, Barnhill RL. Epidemiology of cutaneous melanoma. An update. Dermatol Clin 1991;9:617-629.
28. Pathak MA. Ultraviolet radiation and the development of non-melanoma and melanoma skin cancer: clinical and experimental evidence. Skin Pharmacol 1991;4(suppl 1):85-94.
29. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999;340:1341-1348.
30. Levine N, Hori Y, Kubota Y. Acquired hypermelanotic disorders. In: Levine N, ed. Pigmentation and Pigmentary Disorders. CRC, Bota Raton, FL, 1993, pp. 211-238.
31. Dunlop D. Eighty-six cases of Addison's disease. Br Med J 1963;5362:887-891.
32. Nerup J. Addison's disease-clinical studies. A report of 108 cases. Acta Endocrinol (Copenh) 1974;76:127-41.
33. Smith AG, Shuster S, Thody AJ, Peberky M. Chloasma, oral contraceptives, and plasma immunore-active P-melanocyte-stimulating hormone. J Invest Dermatol 1977;68:169-170.
34. Stulberg DL, Clark N, Tovey D. Common hyperpigmentation disorders in adults: Part II. Melanoma, seborrheic keratoses, acanthosis nigricans, melasma, diabetic dermopathy, tinea versicolor, and postinflammatory hyperpigmentation. Am Fam Physician 2003;68:1963-1968.
35. Snell RS. The pigmentary changes occurring in the breast skin during pregnancy and following estrogen treatment. J Invest Dermatol 1964;43:181-186.
36. Wilson MJ, Spaziani E. The melanogenic response to testosterone in scrotal epidermis; the effects on tyrosinase activity and protein synthesis. Acta Endocrin 1976;81:435-448.
37. Friedmann PS, Wren F, Buffey J, MacNeil S. a-MSH causes a small rise in cAMP but has no effect on basal or ultraviolet-stimulated melanogenesis in human melanocytes. Br J Dermatol 1990; 123:145-151.
38. Halaban R, Tyrrell L, Longley J, Yarden Y, Rubin J. Pigmentation and proliferation of human melanocytes and the effects of melanocyte-stimulating hormone and ultraviolet B light. Ann N Y Acad Sci 1993;680:290-301.
39. Fuller BB, Rungta D, Iozumi K, et al. Hormonal regulation of melanogenesis in mouse melanoma and in human melanocytes. Ann N Y Acad Sci 1993;680:302-319.
40. Tomita Y, Maeda K, Tagami H. Mechanisms for hyperpigmentation in postinflammatory pigmentation, urticaria pigmentosa and sunburn. Dermatologica 1989;179(suppl 1):49-53.
41. Thestrup-Pedersen K, Larsen CS, Kristensen M, Zachariae C. Interleukin-1 release from peripheral blood monocytes and soluble interleukin-2 and cd8 receptors in serum from patients with atopic dermatitis. Acta Derm Venereol 1990;70:395-399.
42. Ferreri NR, Millet I, Paliwal V, et al. Induction of macrophage TNF alpha, IL-1, IL-6, and PGE2 production by DTH-initiating factors. Cell Immunol 1991;137:389-405.
43. Ford-Hutchinson AW, Rackman A. Leukotrienes as mediators of skin inflammation. Br J Dermatol 1983;109(suppl 25):26-29.
44. 4 are present in biologically active concentrations. J Allergy Clin Immunol 1989;83:450-455.
45. Tomita Y, Maeda K, Tagami H. Histamine stimulates normal human melanocytes in vitro: one of the possible inducers of hyperpigmentation in urticaria pigmentosa. J Dermatol Sci 1993;6:146-154.
46. Yoshida M, Takahashi Y, Inoue S. Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes. J Invest Dermatol 2000;114:334-342.
47. Gordon PR, Mansur CP, Gilchrest BA. Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors. J Invest Dermatol 1989;92:565-572.
48. Toyoda M, Luo Y, Makino T, Matsui C, Morohashi M. Calcitonin gene-related peptide upregulates melanogenesis and enhances melanocyte dendricity via induction of keratinocyte-derived melanotrophic factors. J Investig Dermatol Symp Proc 1999;4:116-125.
49. Imokawa G, Yada Y, Morisaki N, Kimura M. Biological characterization of human fibroblast-derived mitogenic factors for human melanocytes. Biochem J 1998;330:1235-1239.
50. Matsui Y, Zsebo KM, Hogan BL. Embryonic expression of a haematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature 1990;347:667-669.
51. Longley BJ Jr, Morganroth GS, Tyrrell L, et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993;328:1302-1307.
52. Matsumoto K, Tajima H, Nakamura T. Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem Biophys Res Commun 1991;176:45-51.
53. Yaar M, Grossman K, Eller M, Gilchrest BA. Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol 1991;115:821-828.
54. Di-Marco E, Marchisio PC, Bondanza S, Franzi AT, Cancedda R, De Luca M. Growth regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 1991;266:21, 718-21, 722.
55. Tron VA, Coughlin MD, Jang DE, Stanisz J, Sauder DN. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 1990;85:1085-1089.
56. Zhai S, Yaar M, Gilchrest BA. Nerve growth factor rescues pigment cells from ultraviolet induced apoptosis by upregulating BCL-2 levels. Exp Cell Res 1996;224:335-343.
57. Yaar M, Eller MS, DiBenedetto P, et al. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest 1994;94:1550-1562.
58. Yamaguchi Y, Itami S, Watabe H, et al. Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J Cell Biol 2004;165:275-285.
59. Swope VB, Abdel-Malek ZA, Kassem L, Nordlund JJ. Interleukins 1a and 6 and tumor necrosis factor-A are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 1991;96:180-185.
60. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor P in human disease. N Engl J Med 2000;342:1350-1358.
61. Krasagakis K, Garbe C, Schrier PI, Orfanos CE. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. Anticancer Res 1994;14:2565-2571.
62. Swope VB, Sauder DN, McKenzie RC, et al. Synthesis of interleukin-1a and P by normal human melanocytes. J Invest Dermatol 1994;102:749-753.
63. Swope VB, Medrano EE, Smalara D, Abdel-Malek Z. Long-term proliferation of human melanocytes is supported by the physiologic mitogens a-melanotropin, endothelin-1, and basic fibroblast growth factor. Exp Cell Res 1995;217:453-459.
64. Suzuki I, Cone R, Im S, Nordlund J, Abdel-Malek Z. Binding capacity and activation of the MC1 receptors by melanotropic hormones correlate directly with their mitogenic and melanogenic effects on human melanocytes. Endocrinology 1996;137:1627-1633.
65. Tada A, Suzuki I, Im S, et al. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ 1998;9:575-584.
66. Bach MK. Mediators of anaphylaxis and inflammation. Ann Rev in Microbiol 1982;36:371-413.
67. Bregman MD, Peters E, Sander D, Meyskens FL Jr. Dexamethasone, prostaglandin A, and retinoic acid modulation of murine and human melanoma cells grown in soft agar. J Natl Cancer Inst 1983;71:927-932.
68. Bregman MD, Funk C, Fukushima M. Inhibition of human melanoma growth by prostaglandin A, D and J analogues. Cancer Res 1986;46:2740-2744.
69. Abdel-Malek Z, Swope VB, Amornsiripanitch N, Nordlund JJ. In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins. Cancer Res 1987;47:3141-3146.
70. 4 as potent mitogens for cultured human melanocytes. J Invest Dermatol 1989;93:719-722.
71. Tomita Y, Maeda K, Tagami H. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res 1992;5:357-361.
72. Krey G, Braissant O, L'Horset F, et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997;11:779-791.
73. 2a on melanocyte dendricity. J Invest Dermatol 2004;122:1214-1224.
74. a by human melanocytes and Cloudman S91 melanoma cells. In: Hammerstrom S, Marnett LW, eds. Prostaglandins, Leukotrienes and Cancer. Boston, MA: Kluwer Academic Press; 1994.
75. Pittelkow MR, Shipley GD. Serum-free culture of normal human melanocytes: growth kinetics and growth factor requirements. J Cell Physiol 1989;140:565-576.
76. Gospodarowicz D, Cohen DC, Fujii DK. Regulation of cell growth by the basal lamina and plasma factors: relevance to embryonic control of cell proliferation. In: Sato G, Pardee A, Sirbasku D, eds. Cold Spring Harbor Conferences on Cell Proliferation 9: Growth of Cells in Hormonally Deficient Media. Vol. 9. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982, pp. 95-124.
77. Cooper CS, Park M, Blair DG, et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984;311:29-33.
78. Park M, Dean M, Cooper CS, et al. Mechanism of met oncogene activation. Cell 1986;45:895-904.
79. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995;376:768-771.
80. Halaban R, Rubin JS, Funasaka Y, et al. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 1992;7:2195-2206.
81. Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit receptor. Cell 1990;63:213-214.
82. Grabbe J, Welker P, Dippel E, Czarnetzki BM. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes [Review]. Arch Dermatol Res 1994;287:78-84.
83. Manova K, Bacharova RF. Expression of c-kit encoded at the W locus of mice in developing embryonic germ cells and presumptive melanoblasts. Dev Biol 1991;146:312-324.
84. Keshet E, Lyman SD, Williams DE, et al. Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J 1991;10:2425-2435.
85. Besmer P, Manova K, Duttlinger R, et al. The {Ikit} ligand (steel factor) and its receptor {Ic-kit/W}: pleiotropic roles in gametogenesis and melanogenesis. Development 1993;(suppl):125-137.
86. Giebel LB, Spritz RA. Mutation of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Proc Natl Acad Sci USA 1991;88:8696-8699.
87. Funasaka Y, Boulton T, Cobb M, et al. c-Kit-Kinase induces a cascade of protein tyrosine phospho-rylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 1992;3:197-209.
88. Grichnik JM, Burch JA, Burchette J, Shea CR. The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol 1998;111:233-238.
89. Scott G, Ewing J, Ryan D, Abboud C. Stem cell factor regulates human melanocyte-matrix interaction. Pigment Cell Res 1994;7:44-51.
90. Scott G, Liang H, Luthra D. Stem cell factor regulates the melanocyte cytoskeleton. Pigment Cell Res 1996;9:134-141.
91. Pincelli C, Yaar M. Nerve growth factor: its significance in cutaneous biology. J Investig Dermatol Symp Proc 1997;2:31-36.
92. Yohn JJ, Morelli JG, Walchak SJ, Rundell KB, Norris DA, Zamora MR. Cultured human keratinocytes synthesize and secrete endothelin-1. J Invest Dermatol 1993;100:23-26.
93. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-415.
94. Baynash AG, Hosoda K, Giaid A, et al. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 1994;79:1277-1285.
95. Imokawa G, Yada Y, Kimura M. Signalling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes. Biochem J 1996;314:305-312.
96. McCallion AS, Chakravarti A. EDNRB/EDN3 and Hirschsprung disease type II. Pigment Cell Res 2001;14:161-169.
97. Tada A, Pereira E, Beitner Johnson D, Kavanagh R, Abdel-Malek ZA. Mitogen and ultraviolet-B-induced signaling pathways in normal human melanocytes. J Invest Dermatol 2002;118:316-322.
98. Lee HO, Levorse JM, Shin MK. The endothelin receptor-B is required for the migration of neural crest-derived melanocyte and enteric neuron precursors. Dev Biol 2003;259:162-175.
99. Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-2867.
100. Puffenberger EG, Hosoda K, Washington SS, et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 1994;79:1257-1266.
101. Murase K, Murakami Y, Takayanagi K, Furukawa Y, Hayashi K. Human fibroblast cells synthesize and secrete nerve growth factor in culture. Biochem Biophys Res Commun 1992;184:373-379.
102. Stefanato CM, Yaar M, Bhawan J, et al. Modulations of nerve growth factor and Bcl-2 in ultraviolet-irradiated human epidermis. J Cutan Pathol 2003;30:351-357.
103. Burbach GJ, Kim KH, Zivony AS, et al. The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor. J Invest Dermatol 2001;117:1075-1082.
104. Kauser S, Schallreuter KU, Thody AJ, Gummer C, Tobin DJ. Regulation of human epidermal mel-anocyte biology by beta-endorphin. J Invest Dermatol 2003;120:1073-1080.
105. Suzuki I, Kato T, Motokawa T, Tomita Y, Nakamura E, Katagiri T. Increase of pro-opiomelanocortin mRNA prior to tyrosinase, tyrosinase-related protein 1, dopachrome tautomerase, Pmel-17/gp100, and P-protein mRNA in human skin after ultraviolet B irradiation. J Invest Dermatol 2002;118:73-78.
106. Slominski A, Ermak G, Mazurkiewicz JE, Baker J, Wortsman J. Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab 1998;83:1020-1024.
107. Eberle AN. Proopiomelanocortin and the melanocortin peptides. In: Cone RD, ed. The Melanocortin Receptors. Humana, Totowa, NJ, 2000, pp. 3-67.
108. Seidah NG, Day R, Marcinkiewicz M, Chretien M. Mammalian paired basic amino acid convertases of prohormones and proproteins. Ann N Y Acad Sci 1993;680:135-146.
109. Abdel-Malek ZA. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 2001;58:434-441.
110. Sawyer TK, Hruby VJ, Hadley ME, Engel MH. a-Melanocyte stimulating hormone: chemical nature and mechanism of action. Am Zool 1983;23:529-540.
111. Castrucci AM, Hadley ME, Hruby VJ. Melanotropin bioassays: in vitro and in vivo comparisons. Gen Comp Endocrinol 1984;55:104-111.
112. Castrucci AML, Hadley ME, Sawyer TK, et al. a-Melanotropin: the minimal active sequence in the lizard skin bioassay. Gen Comp Endocrinol 1989;73:157-163.
113. Visconti MA, Ramanzini GC, Camargo CR, Castrucci AM. Elasmobranch color change: a short review and novel data on hormone regulation. J Exp Zool 1999;284:485-491.
114. Geschwind II, Huseby RA, Nishioka R. The effect of melanocyte-stimulating hormone on coat color in the mouse. Rec Prog Hormone Res 1972;28:91-130.
115. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science 1992;257:1248-1251.
116. Chhajlani V, Wikberg JES. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 1992;309:417-420.
117. 7 a-melanocyte-stimulating hormone increases the eumelanin: phaeomelanin ratio in cultured human melanocytes. J Invest Dermatol 1995;104:83-85.
118. Hunt G, Donatien PD, Lunec J, Todd C, Kyne S, Thody AJ. Cultured human melanocytes respond to MSH peptides and ACTH. Pigment Cell Res 1994;7:217-221.
119. Scott MC, Suzuki I, Abdel-Malek ZA. Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors, and by UV radiation. Pigment Cell Res 2002;15:433-439.
120. Tamate HB, Takeuchi T. Action of the e locus of mice in the response of phaeomelanic hair follicles to a-melanocyte-stimulating hormone in vitro. Science 1984;224:1241-1242.
121. Robbins LS, Nadeau JH, Johnson KR, et al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993;72:827-834.
122. Abdel-Malek ZA, Scott MC, Furumura M, et al. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J Cell Sci 2001;114:1019-1024.
123. Siracusa LD. The agouti gene: turned on to yellow. Trends Genet 1994;10:423-428.
124. Kwon HY, Bultman SJ, Loffler C, et al. Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc Natl Acad Sci USA 1994;91:9760-9764.
125. Wilson BD, Ollmann MM, Kang L, Stoffel M, Bell GI, Barsh GS. Structure and function of ASP, the human homolog of the mouse agouti gene. Hum Mol Genet 1995;4:223-230.
126. Suzuki I, Tada A, Ollmann MM, et al. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to a-melanotropin. J Invest Dermatol 1997;108:838-842.
127. Voisey J, Box NF, van Daal A. A polymorphism study of the human Agouti gene and its association with MC1R. Pigment Cell Res 2001;14:264-267.
128. Kanetsky PA, Swoyer J, Panossian S, Holmes R, Guerry D, Rebbeck TR. A polymorphism in the agouti signaling protein gene is associated with human pigmentation. Am J Hum Genet 2002;70:770-775.
129. Harding RM, Healy E, Ray AJ, et al. Evidence for variable selective pressures at MC1R. Am J Hum Genet 2000;66:1351-1361.
130. Box NF, Wyeth JR, O'Gorman LE, Martin NG, Sturm RA. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 1997;6:1891-1897.
131. Smith R, Healy E, Siddiqui S, et al. Melanocortin 1 receptor variants in Irish population. J Invest Dermatol 1998;111:119-122.
132. Palmer JS, Duffy DL, Box NF, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000;66:176-186.
133. Bastiaens MT, ter Huurne JAC, Kielich C, et al. Melanocortin-1 receptor gene variants determine the risk of non-melanoma skin cancer independent of fair skin type and red hair. Am J Hum Genet 2001;68:884-894.
134. Scott MC, Wakamatsu K, Ito S, et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to ultraviolet radiation. J Cell Sci 2002;115:2349-2355.
135. Duffy DL, Box NF, Chen W, et al. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 2004;13:447-461.
136. Kauser S, Thody AJ, Schallreuter KU, Gummer CL, Tobin DJ. beta-Endorphin as a regulator of human hair follicle melanocyte biology. J Invest Dermatol 2004;123:184-195.
137. Babiarz-Magee L, Chen N, Seiberg M, Lin CB. The expression and activation of protease-activated receptor-2 correlate with skin color. Pigment Cell Res 2004;17:241-251.
138. Epstein JH. Photocarcinogenesis, skin cancer and aging. J Am Acad Dermatol 1983;9:487-502.
139. Rees JL. Genetics of hair and skin color. Annu Rev Genet 2003;37:67-90.
140. Tadokoro T, Kobayashi N, Zmudzka BZ, et al. UV-induced DNA damage and melanin content in human skin differing in racial/ethnic origin. FASEB J 2003 [online]. April 8, 2003;express article 10.1096/fj.02-0865fje.
141. Barker D, Dixon K, Medrano EE, et al. Comparison of the responses of human melanocytes with different melanin contents to ultraviolet B irradiation. Cancer Res 1995;55:4041-4046.
142. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991;88:10, 124-10, 128.
143. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994;372:773-776.
144. Pollock PM, Yu F, Qiu L, Parsons PG, Hayward NK. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines. Oncogene 1995;11:663-668.
145. Flores JF, Walker GJ, Glendening JM, et al. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res 1996;56:5023-5032.
146. Chedekel MR, Smith SK, Post PW, Pokora A, Vessell DL. Photodestruction of pheomelanin: role of oxygen. Proc Natl Acad Sci USA 1978;75:5395-5399.
147. Smit NPM, Vink AA, Kolb RM, et al. Melanin offers protection against induction of cyclobutane pyrimidine dimers and 6-4 photoproducts by UVB in cultured human melanocytes. Photochem Photobiol 2001;74:424-430.
148. Hachiya A, Kobayashi A, Ohuchi A, Takema Y, Imokawa G. The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation. J Invest Dermatol 2001;116:578-586.
149. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004;17:96-110.
150. 2a in human skin at 6 and 24 h after ultraviolet B irradiation (290-320 nm). Br J Clin Pharmacol 1978;5:431-436.
151. Kupper TS, Chua AO, Flood P, McGuire J, Gubler U. Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 1987;80:430-436.
152. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995;105:32-37.
153. Im S, Moro O, Peng F, et al. Activation of the cAMP pathway by a-melanotropin mediates the response of human melanocytes to UVB light. Cancer Res 1998;58:47-54.
154. Westbroek W, Lambert J, Naeyaert JM. The dilute locus and Griscelli syndrome: gateways towards a better understanding of melanosome transport. Pigment Cell Res 2001;14:320-327.
155. Seiberg M, Paine C, Sharlow E, et al. The protease-activated receptor-2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 2000;254:25-32.
156. Seiberg M, Paine C, Sharlow E, et al. Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol 2000;115:162-167.
157. Scott G, Deng A, Rodriguez-Burford C, et al. Protease-activated receptor 2, a receptor involved in melanosome transfer, is upregulated in human skin by ultraviolet irradiation. J Invest Dermatol 2001;117:1412-1420.
158. Scott G. Rac and rho: the story behind melanocyte dendrite formation. Pigment Cell Res 2002; 15:322-330.
159. Klein-Parker HA, Warshawski L, Tron VA. Melanocytes in human skin express bcl-2 protein. J Cutan Pathol 1994;21:297-301.
160. Plettenberg A, Ballaun C, Pammer J, et al. Human melanocytes and melanoma cells constitutively express the bcl-2 proto-oncogene in situ and in cell culture. Am J Pathol 1995;146:651-659.
161. Kadekaro AL, Kanto H, Kavanagh RJ, Schwemberger S, Babcock G, Abdel-Malek ZA. A novel role for the paracrine factors endothelin-1 and alpha-melanocortin as survival factors for human melanocytes. Pigment Cell Res 2003;16: 416(Abstract).
162. Larribere L, Khaled M, Tartare-Deckert S, et al. PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Cell Death Differ 2004.
163. Kadekaro AL, Kavanagh R, Kanto H, et al. a-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 2005;65:4292-4299.
164. Rouzaud F, Kadekaro AL, Abdel-Malek ZA, Hearing VJ. MC1R and the response of melanocytes to ultraviolet radiation. Mutat Res 2005;571:133-152.
165. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-241.
166. Pugazhenthi S, Nesterova A, Sable C, et al. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 2000;275:10, 761-10, 766.
167. Price ER, Horstmann MA, Wells AG, et al. a-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem 1998;273: 33, 042-33, 047.
168. McGill GG, Horstmann M, Widlund HR, et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002;109:707-718.
169. Liede A, Karlan BY, Narod SA. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 2004;22:735-742.
170. Wong AK, Pero R, Ormonde PA, Tavtigian SV, Bartel PL. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 1997;272:31, 941-31, 944.
171. Chen PL, Chen CF, Chen Y, Xiao J, Sharp ZD, Lee WH. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc Natl Acad Sci USA 1998;95:5287-5292.